Elevated fecal and serum calprotectin in COVID-19 are not consistent with gastrointestinal symptoms
Abstract Intestinal epithelial cell damage caused by SARS-CoV-2 infection was thought to be associated with gastrointestinal symptoms and decreased fecal consistency. The association of the gastrointestinal symptoms with the COVID-19-mediated inflammatory response triggered by the gastrointestinal i...
Guardado en:
Autores principales: | Hajar Shokri-Afra, Ahmad Alikhani, Bahman Moradipoodeh, Farshid Noorbakhsh, Hafez Fakheri, Hemen Moradi-Sardareh |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e3830e34d4924d4a8b30f4751c3ab77d |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Fecal calprotectin and microbiota of the gut
por: V. G. Gorokhova, et al.
Publicado: (2016) -
Fecal calprotectin in healthy children aged 4–16 years
por: María Roca, et al.
Publicado: (2020) -
Combined Use of Fecal Biomarkers in Inflammatory Bowel Diseases: Oncostatin M and Calprotectin
por: Cao Y, et al.
Publicado: (2021) -
Fecal Microbiota Transplantation Relieves Gastrointestinal and Autism Symptoms by Improving the Gut Microbiota in an Open-Label Study
por: Ning Li, et al.
Publicado: (2021) -
Corrigendum: Fecal Microbiota Transplantation Relieves Gastrointestinal and Autism Symptoms by Improving the Gut Microbiota in an Open-Label Study
por: Ning Li, et al.
Publicado: (2021)